Naren completed his MSc in Biotechnology from the University of Madras, then earned his Ph.D. in Physiology from the National University of Singapore (NUS) under mentor, Dr. Reshma Taneja. His Ph.D. thesis, investigating the role of G9a in skeletal muscle differentiation addressed epigenetic factors in muscle stem cells and muscle progenitor cells. His finding was published in Proceedings of the National Academy of Sciences. Naren joined as a postdoctoral fellow at cc-TDI in November 2015.
His research work involves investigating the mechanisms of a novel epigenetic therapy for children with muscle cancer (rhabdomyosarcoma). His preclinical investigation of a kinase inhibitor in rhabdomyosarcoma was published recently in Oncotarget. Naren’s previous postdoctoral work with Dr. Taneja also addressed rhabdomyosarcoma and has been published in The Journal of Pathology in 2016. We are privileged to have Naren’s muscle biology and stem cell expertise in our group.
